Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2016-05-16

Clinical Trial Update: Post Marketing Surveillance for Contac Bien Z in Japan

View source ↗

Summary

Post-marketing safety surveillance for Contac Bien Z in Japan has been completed. The surveillance evaluated safety in patients with allergic rhinitis and seaso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Contac Bien Z

Snippet

Sponsor: GlaxoSmithKline | Conditions: Allergic Rhinitis, Seasonal Allergic Rhinitis | Status: COMPLETED